Combination of rRT-PCR and Clinical Features to Predict Coronavirus Disease 2019 for Nosocomial Infection Control
Fumihiro Yamaguchi,Ayako Suzuki,Miyuki Hashiguchi,Emiko Kondo,Atsuo Maeda,Takuya Yokoe,Jun Sasaki,Yusuke Shikama,Munetaka Hayashi,Sei Kobayashi,Hiroshi Suzuki
DOI: https://doi.org/10.2147/idr.s432198
2024-01-18
Infection and Drug Resistance
Abstract:Fumihiro Yamaguchi, 1 Ayako Suzuki, 2 Miyuki Hashiguchi, 3 Emiko Kondo, 3 Atsuo Maeda, 4 Takuya Yokoe, 1 Jun Sasaki, 4 Yusuke Shikama, 1 Munetaka Hayashi, 4 Sei Kobayashi, 5 Hiroshi Suzuki 6 1 Department of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan; 2 Department of Pharmacy, Showa University Fujigaoka Hospital, Yokohama, Japan; 3 Department of Infection Control, Showa University Fujigaoka Hospital, Yokohama, Japan; 4 Department of Emergency and Critical Care Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan; 5 Department of Otolaryngology, Showa University Fujigaoka Hospital, Yokohama, Japan; 6 Department of Cardiology, Showa University Fujigaoka Hospital, Yokohama, Japan Correspondence: Fumihiro Yamaguchi, Department of Respiratory Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, 227-8501, Japan, Email Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), immediately became a pandemic. Therefore, nosocomial infection control is necessary to screen for patients with possible COVID-19. Objective: This study aimed to investigate commonly measured clinical variables to predict COVID-19. Methods: This cross-sectional study enrolled 1087 patients in the isolation ward of a university hospital. Conferences were organized to differentiate COVID-19 from non-COVID-19 cases, and multiple nucleic acid tests were mandatory when COVID-19 could not be excluded. Multivariate logistic regression models were employed to determine the clinical factors associated with COVID-19 at the time of hospitalization. Results: Overall, 352 (32.4%) patients were diagnosed with COVID-19. The majority of the non-COVID-19 cases were predominantly caused by bacterial infections. Multivariate analysis indicated that COVID-19 was significantly associated with age, sex, body mass index, lactate dehydrogenase, C-reactive protein, and malignancy. Conclusion: Some clinical factors are useful to predict patients with COVID-19 among those with symptoms similar to COVID-19. This study suggests that at least two real-time reverse-transcription polymerase chain reactions of SARS-CoV-2 are recommended to exclude COVID-19. Keywords: severe acute respiratory syndrome coronavirus-2, coronavirus disease 2019, nosocomial infection control, nucleic acid test, obesity, cross sectional study, Japan The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) first emerged at the end of 2019. Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 subsequently became a pandemic and remains a burden to humans. Because COVID-19 has no characteristic symptoms, 1,2 nucleic acid or antigen tests to detect the N gene or N protein of SARS-CoV-2 are necessary for the diagnosis; however, false-negative results are a critical medical problem. 3,4 In November 2020, we experienced a large cluster of COVID-19 in our institute because a few patients with COVID-19 were missed. At that time, a single nucleic acid test was used to determine whether a patient had COVID-19. Thereafter, significant changes in nosocomial infection control of COVID-19 were established in our institute. More specifically, we organized conferences of respiratory physicians to differentiate COVID-19 from non-COVID-19 cases and decided to transfer patients without COVID-19 from the isolation ward to the general ward. In addition, multiple nucleic acid tests should be performed if COVID-19 could not be excluded based on physical and imaging findings even if a nucleic acid test was negative. This strategy may be effective in future pandemic events. It is necessary to screen patients with possible COVID-19 for nosocomial infection control. Previous studies have mostly focused on mortality-related factors of COVID-19. 5–9 However, only a few studies have analyzed the risk of COVID-19. Since November 2021, omicron variants have been reported worldwide, and there is growing concern about its infectivity, transmissibility, and antigenicity. 10,11 Most notably, BA.5, an omicron variant that has been endemic in Japan since July 2022, has a predominance of increased infection and immune escape, compared with previous lineages. 12 Meanwhile, the previous lineages had a higher rate of severe illness and mortality than BA.5, making it crucial to prevent horizontal nosocomial transmission by strict isolation. In this study, we aimed to investigate the efficacy of clinical factors to predict patients with COVID-19 in the isolation ward befor -Abstract Truncated-
pharmacology & pharmacy,infectious diseases